This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
ISRG Stock Falls Despite Q4 Earnings Beat & Robust Procedures
by Zacks Equity Research
ISRG's fourth-quarter results reflect a healthy demand for procedures. Higher pricing boosts procedure sales. An improvement in margins buoys well.
Intuitive Surgical (ISRG) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Intuitive Surgical (ISRG) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Markets Ramp Up to End Session; Q4 Beats for TXN, ISRG
by Mark Vickery
Markets finished in robust fashion in the green today, ramping up in the final 20 minutes of trading.
Intuitive Surgical, Inc. (ISRG) Q4 Earnings Surpass Estimates
by Zacks Equity Research
Intuitive Surgical (ISRG) delivered earnings and revenue surprises of 24.86% and 0.02%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Initial Claims Higher-Than-Estimates
by Zacks Equity Research
Initial Claims Higher-Than-Estimates
Pre-Markets Seek Direction on Warmer Jobless Claims, Q4 Earnings
by Mark Vickery
While new and continuing jobless claims both move higher, American Airlines and GE Aerospace release Q4 earnings.
S&P 500 Misses New Closing High by 4 Points
by Mark Vickery
The S&P came close to closing at a new all-time high today at 6,086, but was just a few points shy of the record close on December 6th of last year.
ISRG Likely to Beat Q4 Expectations: How to Play the Stock?
by Indrajit Bandyopadhyay
Intuitive Surgical's fourth-quarter results are likely to reflect solid performance in the company's Instruments & Accessories segment. Improving margins buoy optimism.
5 Stocks to Watch for Earnings This Week
by Tracey Ryniec
Zacks Stock Strategist, Tracey Ryniec, discusses 5 stock charts, including Netflix.
Exploring Analyst Estimates for Intuitive Surgical (ISRG) Q4 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Evaluate the expected performance of Intuitive Surgical (ISRG) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Intuitive Surgical, Inc. (ISRG) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the closing of the recent trading day, Intuitive Surgical, Inc. (ISRG) stood at $584.08, denoting a +0.68% change from the preceding trading day.
Intuitive Surgical, Inc. (ISRG) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Intuitive Surgical (ISRG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Intuitive Surgical Stock Surges on Q4 Preliminary Revenue Beat
by Zacks Equity Research
ISRG records significant growth in the top line, driven by higher system placements as well as improved pricing. Procedure volume remains strong.
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching Intuitive Surgical (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Intuitive Surgical, Inc. (ISRG) Advances While Market Declines: Some Information for Investors
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) concluded the recent trading session at $547.47, signifying a +0.63% move from its prior day's close.
Intuitive Surgical, Inc. (ISRG) Ascends While Market Falls: Some Facts to Note
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) reachead $524.03 at the closing of the latest trading day, reflecting a +0.4% change compared to its last close.
Will Intuitive Surgical (ISRG) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Intuitive Surgical (ISRG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
5 MedTech Stocks That Are Poised to Beat the Market in 2025
by Harshit Gupta
Here, we discuss five stocks that are likely to generate better than the market, driven by strong demand for existing products and the addition of innovative new devices.
Intuitive Surgical, Inc. (ISRG) Stock Moves -0.73%: What You Should Know
by Zacks Equity Research
The latest trading day saw Intuitive Surgical, Inc. (ISRG) settling at $534.88, representing a -0.73% change from its previous close.
Intuitive Surgical, Inc. (ISRG) Rises As Market Takes a Dip: Key Facts
by Zacks Equity Research
In the most recent trading session, Intuitive Surgical, Inc. (ISRG) closed at $538.83, indicating a +0.34% shift from the previous trading day.
Intuitive Surgical, Inc. (ISRG) Declines More Than Market: Some Information for Investors
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $523.91, moving -0.49% from the previous trading session.
Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
Intuitive Surgical, Inc. (ISRG) Stock Moves -0.94%: What You Should Know
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) concluded the recent trading session at $539.58, signifying a -0.94% move from its prior day's close.
The Zacks Analyst Blog Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen
by Zacks Equity Research
Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen are included in this Analyst Blog.